Business Wire
BusinessDimon warns JPM customers about AI agents and “liability transfer” risksThe Apex TimesBusinessUnitedHealth shares pull back after profit outlook rise boosts early momentumThe Apex TimesBusinessL3Harris shares face investor spotlight as THAAD and counter-drone wins pile upThe Apex TimesBusinessHumana plans $2.8 billion primary care deal with BlackRock, expanding CenterWell clinic ownershipThe Apex TimesBusinessCoinbase eyes an “everything exchange” in Australia, moving from crypto into stocks, derivatives and prediction marketsThe Apex TimesBusinessAmazon Investors Weigh Late-October Timing as Market Turns to What’s NextThe Apex TimesBusinessAmazon in talks to buy Decart in a deal reported around $7 billion, indicating continued push into AI softwareThe Apex TimesBusinessBerkshire Hathaway’s shares face a valuation reality check as investors ask whether returns can keep paceThe Apex TimesBusinessPepsiCo faces renewed dividend anxiety after sharp guidance cut and share drop, market commentary saysThe Apex TimesBusinessEli Lilly’s valuation premium may depend on how long its fast revenue growth can last, analysts sayThe Apex TimesBusinessApple delays sales of its latest product in Europe amid ongoing AI-related EU disputeThe Apex TimesBusinessFord’s next earnings test: market hopes hinge on its recent ability to top estimatesThe Apex TimesBusinessDimon warns JPM customers about AI agents and “liability transfer” risksThe Apex TimesBusinessUnitedHealth shares pull back after profit outlook rise boosts early momentumThe Apex TimesBusinessL3Harris shares face investor spotlight as THAAD and counter-drone wins pile upThe Apex TimesBusinessHumana plans $2.8 billion primary care deal with BlackRock, expanding CenterWell clinic ownershipThe Apex TimesBusinessCoinbase eyes an “everything exchange” in Australia, moving from crypto into stocks, derivatives and prediction marketsThe Apex TimesBusinessAmazon Investors Weigh Late-October Timing as Market Turns to What’s NextThe Apex TimesBusinessAmazon in talks to buy Decart in a deal reported around $7 billion, indicating continued push into AI softwareThe Apex TimesBusinessBerkshire Hathaway’s shares face a valuation reality check as investors ask whether returns can keep paceThe Apex TimesBusinessPepsiCo faces renewed dividend anxiety after sharp guidance cut and share drop, market commentary saysThe Apex TimesBusinessEli Lilly’s valuation premium may depend on how long its fast revenue growth can last, analysts sayThe Apex TimesBusinessApple delays sales of its latest product in Europe amid ongoing AI-related EU disputeThe Apex TimesBusinessFord’s next earnings test: market hopes hinge on its recent ability to top estimatesThe Apex TimesBusinessDimon warns JPM customers about AI agents and “liability transfer” risksThe Apex TimesBusinessUnitedHealth shares pull back after profit outlook rise boosts early momentumThe Apex TimesBusinessL3Harris shares face investor spotlight as THAAD and counter-drone wins pile upThe Apex TimesBusinessHumana plans $2.8 billion primary care deal with BlackRock, expanding CenterWell clinic ownershipThe Apex TimesBusinessCoinbase eyes an “everything exchange” in Australia, moving from crypto into stocks, derivatives and prediction marketsThe Apex TimesBusinessAmazon Investors Weigh Late-October Timing as Market Turns to What’s NextThe Apex TimesBusinessAmazon in talks to buy Decart in a deal reported around $7 billion, indicating continued push into AI softwareThe Apex TimesBusinessBerkshire Hathaway’s shares face a valuation reality check as investors ask whether returns can keep paceThe Apex TimesBusinessPepsiCo faces renewed dividend anxiety after sharp guidance cut and share drop, market commentary saysThe Apex TimesBusinessEli Lilly’s valuation premium may depend on how long its fast revenue growth can last, analysts sayThe Apex TimesBusinessApple delays sales of its latest product in Europe amid ongoing AI-related EU disputeThe Apex TimesBusinessFord’s next earnings test: market hopes hinge on its recent ability to top estimatesThe Apex TimesBusinessDimon warns JPM customers about AI agents and “liability transfer” risksThe Apex TimesBusinessUnitedHealth shares pull back after profit outlook rise boosts early momentumThe Apex TimesBusinessL3Harris shares face investor spotlight as THAAD and counter-drone wins pile upThe Apex TimesBusinessHumana plans $2.8 billion primary care deal with BlackRock, expanding CenterWell clinic ownershipThe Apex TimesBusinessCoinbase eyes an “everything exchange” in Australia, moving from crypto into stocks, derivatives and prediction marketsThe Apex TimesBusinessAmazon Investors Weigh Late-October Timing as Market Turns to What’s NextThe Apex TimesBusinessAmazon in talks to buy Decart in a deal reported around $7 billion, indicating continued push into AI softwareThe Apex TimesBusinessBerkshire Hathaway’s shares face a valuation reality check as investors ask whether returns can keep paceThe Apex TimesBusinessPepsiCo faces renewed dividend anxiety after sharp guidance cut and share drop, market commentary saysThe Apex TimesBusinessEli Lilly’s valuation premium may depend on how long its fast revenue growth can last, analysts sayThe Apex TimesBusinessApple delays sales of its latest product in Europe amid ongoing AI-related EU disputeThe Apex TimesBusinessFord’s next earnings test: market hopes hinge on its recent ability to top estimatesThe Apex Times
Back to front
L3Harris says its VAMPIRE counter-drone system has surpassed 350,000 operational hours in European combat support
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 13, 11:43 AM EDT

L3Harris says its VAMPIRE counter-drone system has surpassed 350,000 operational hours in European combat support

The defense contractor also pointed to a separate GMLRS-related effort tied to a planned Arkansas facility, as it highlights growing demand for counter-UAS capabilities.

L3Harris said it has delivered the first counter-drone systems using its VAMPIRE technology to the U.S. Army, according to a market report that summarized the company’s update. VAMPIRE, an acronym for a “Vehicle and Aerial Modular Palletized Rapid- Integration” solution, is designed to detect and engage drones, offering a modular way to bring counter-unmanned capabilities to field units.

The company’s update also included operational metrics intended to show that the system is being used in real-world conditions. L3Harris said its VAMPIRE technology has logged more than 350,000 operational hours since 2023 in support of European combat operations, framing the experience as a proof point for reliability and sustained deployment rather than a one-off demonstration.

Beyond the VAMPIRE milestone, the same report referenced a separate effort involving GMLRS. GMLRS stands for Guided Multiple Launch Rocket System, a family of artillery rockets used for precision strikes, and the company indicated it will fulfill a GMLRS contract at a planned facility in Arkansas. L3Harris did not, in the material available here, provide additional specifics such as expected capacity, timing, or the contract’s dollar value.

While the report focuses on deliveries and program momentum, it does not spell out details that defense procurement watchers typically look for, including how many VAMPIRE systems were delivered as part of the U.S. Army handoff, which Army unit received the first fielded systems, or what particular configuration or engagement package is included. It also does not describe the integration approach for U.S. Army platforms beyond the fact of delivery.

In counter-drone procurement, the practical question is often how quickly systems can be fielded and how well they perform under changing threat conditions, including different drone sizes and operating profiles. L3Harris’ emphasis on accumulated operational hours suggests the company is trying to strengthen the argument that its solution is already validated by ongoing use, a factor that can matter when customers seek faster adoption of counter-UAS tools.

The GMLRS mention places L3Harris in the broader picture of artillery and precision fires modernization, where demand has been driven by stockpile rebuilding and ongoing operational requirements across Europe and the Middle East. For a contractor, a planned Arkansas facility indicates that the work is not just near-term hardware deliveries but also industrial scaling, though the report does not provide dates or what portion of the production or assembly work would occur there.

As with many program updates shared through market-news channels, several points remain unspecified. The available material does not disclose the U.S. Army contract number, delivery timeline beyond “first” systems, performance details such as engagement range or target set, or how VAMPIRE is being measured against specific Army evaluation criteria. It also does not say whether the Arkansas facility would support only the cited GMLRS contract or additional rocket or rocket-related work.

Looking ahead, investors and defense customers will likely watch for additional disclosures that connect these announcements to procurement paperwork and execution. That could include formal contract awards, unit-level fielding updates for VAMPIRE in the Army, and further description of the Arkansas facility plan, such as permitting, construction milestones, and production start dates, to understand how quickly the capacity buildout could respond to demand.

Why It Matters

  • Counter-UAS procurement is accelerating, and field deliveries can be a announcement of program transition from evaluation to operational use.
  • Accumulated “operational hours” claims may influence customer confidence by emphasizing ongoing deployment rather than a single test event.
  • Industrial capacity expansion for precision munitions, such as the planned Arkansas facility, is a key constraint in meeting demand.
  • Lack of specifics in the public update means observers will likely seek subsequent contract filings or company disclosures to gauge scale and timelines.

Sources

Key Facts

  • L3Harris said it has delivered the first VAMPIRE counter-drone systems to the U.S. Army.
  • L3Harris reported that its VAMPIRE technology has logged more than 350,000 operational hours since 2023 supporting European combat operations.
  • VAMPIRE is presented as a modular counter-drone solution intended for field integration.
  • The report also referenced a GMLRS-related contract tied to a planned facility in Arkansas.
  • The market report did not provide contract values, delivery quantities, or unit-level details in the material reviewed.

Defense Related

Oct 13, 12:43 PM EDT
The Apex Times

L3Harris shares face investor spotlight as THAAD and counter-drone wins pile up

A Yahoo Finance report said investors are weighing L3Harris Technologies’ expanding missile propulsion and counter-drone work, including more than $6 billion in THAAD propulsion awards tied to Lockheed Martin and additional precision-guided rocket propulsion business.

L3Harris shares face investor spotlight as THAAD and counter-drone wins pile up
The Apex Times
L3Harris says its VAMPIRE counter-drone system has surpassed 350,000 operational hours in European combat support | The Apex Times